Dr. Carl-Christian Jackson, MD

NPI: 1235355173
Total Payments
$1,922
2021 Payments
$1,000
Companies
3
Transactions
11

Payment Breakdown by Category

Consulting$1,000 (52.0%)
Travel$675.12 (35.1%)
Food & Beverage$247.19 (12.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $1,000 1 52.0%
Travel and Lodging $675.12 4 35.1%
Food and Beverage $247.19 6 12.9%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme Corporation $1,865 9 $0 (2021)
TEI Biosciences Inc $36.21 1 $0 (2018)
KCI USA, Inc $21.00 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2021 $1,000 1 Merck Sharp & Dohme Corporation ($1,000)
2019 $21.00 1 KCI USA, Inc ($21.00)
2018 $36.21 1 TEI Biosciences Inc ($36.21)
2017 $865.10 8 Merck Sharp & Dohme Corporation ($865.10)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
04/07/2021 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Consulting Fee Cash or cash equivalent $1,000.00 General
Category: INFECTIOUS DISEASE
06/04/2019 KCI USA, Inc ACTIVAC (Device) Food and Beverage In-kind items and services $21.00 General
Category: DEVICES
09/24/2018 TEI Biosciences Inc SURGIMEND (Device) Food and Beverage In-kind items and services $36.21 General
Category: RECON-SKIN AND WOUND
10/23/2017 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Travel and Lodging Cash or cash equivalent $52.00 General
Category: INFECTIOUS DISEASE
09/20/2017 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Travel and Lodging In-kind items and services $58.38 General
Category: INFECTIOUS DISEASE
09/20/2017 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Food and Beverage In-kind items and services $50.00 General
Category: INFECTIOUS DISEASE
09/20/2017 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Food and Beverage In-kind items and services $34.99 General
Category: INFECTIOUS DISEASE
09/20/2017 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Food and Beverage In-kind items and services $20.00 General
Category: INFECTIOUS DISEASE
09/19/2017 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Travel and Lodging In-kind items and services $344.39 General
Category: INFECTIOUS DISEASE
09/19/2017 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Travel and Lodging In-kind items and services $220.35 General
Category: INFECTIOUS DISEASE
09/19/2017 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Food and Beverage In-kind items and services $84.99 General
Category: INFECTIOUS DISEASE

About Dr. Carl-Christian Jackson, MD

Dr. Carl-Christian Jackson, MD is a Thoracic Surgery (Cardiothoracic Vascular Surgery) healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235355173.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carl-Christian Jackson, MD has received a total of $1,922 in payments from pharmaceutical and medical device companies, with $1,000 received in 2021. These payments were reported across 11 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($1,000).

Practice Information

  • Specialty Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • Other Specialties Pediatric Surgery, Pediatric Surgery
  • Location Providence, RI
  • Active Since 04/18/2007
  • Last Updated 11/26/2025
  • Taxonomy Code 208G00000X
  • Entity Type Individual
  • NPI Number 1235355173

Products in Payments

  • ZERBAXA (Drug) $1,865
  • SURGIMEND (Device) $36.21
  • ACTIVAC (Device) $21.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Thoracic Surgery (Cardiothoracic Vascular Surgery) Doctors in Providence